维普中文期刊产品整合服务
15篇 您的检索式:作者名="Gargante"
    题名 作者 年代 出处 被引量
1Decrease of serum carnitine levels in patients with or without gastrointestinal cancer cachexia显示文摘瞄准:在消化机关与癌症在病人评估浆液肉毒碱的层次并且把他们与另外的癌症作比较以便提供新卓见进极度瘦弱的机制。方法:55 个恶病质病人与或没有胃肠的癌症在现在的学习被注册。他们经历了平淡的实验室调查,包括在浆液在场的肉毒碱的各种各样的形式的层次的检查(即,长链的酰肉毒碱,短链的酰肉毒碱,免费肉毒碱,和全部的肉毒碱) 。这些价值与 30 个健康控制题目在好营养的地位以及与那些在 60 个癌症病人发现的那些相比。结果:当没有胃肠的癌症,有胃肠的癌症的恶病质病人与恶病质病人相比时,差别是在免费肉毒碱的 -6.8 micromol/L (P < 0.005 ) ,在长链酰肉毒碱的 0.04 micromol/L (P < 0.05 ) ,在全部的肉毒碱的 8.7 micromol/L (P < 0.001 ) 。在恶病质病人与或没有胃肠的癌症,差别是在免费肉毒碱的 12.2 micromol/L ( P < 0.001 ),在短链酰肉毒碱的 4.60 micromol/L ( P < 0.001 ),并且在长链的酰肉毒碱的 0.60 微摩尔 /L ( P < 0.005 )并且在全部的肉毒碱的 17.4 micromol/L ( P < 0.001 )。在有胃肠的癌症和健康控制题目的恶病质病人,差别是在免费肉毒碱的 15.5 micromol/L ( P < 0.001 ),在短链的酰肉毒碱的 5.2 微摩尔 /L ( P < 0.001 ),在长链酰肉毒碱的 1.0 micromol/L ( P < 0.001 ),并且在全部的肉毒碱的 21.8 micromol/L ( P < 0.001 )。结论:在终端的肉毒碱的低浆液层次肿瘤的病人由于减少的饮食的吸入极大地被减少并且损害了这种物质的内长的合成。这些低浆液肉毒碱层次也在癌症病人贡献极度瘦弱的前进。Mariano Malaguarnera Corrado Risino Maria Pia Gargante Giovanni Oreste Gloria Barone Anna Veronica Tomasello Mario Costanzo Matteo Angelo Cannizzaro 2006World Journal of Gastroenterology2006,12,28:3
2Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephaio-pathy显示文摘Malaguarnera M Gargante MP Malaguamera G 2010Eur J Gastroenterol Hepatol2010,22,2:1
3Bifidobacterium longum with Fructo-Oligosaccharide (FOS) Treatment in Minimal Hepatic Encephalopathy: A Randomized, Double-Blind, Placebo-Controlled Study显示文摘Mariano Malaguarnera Filippo Greco Gloria Barone Maria Pia Gargante Michele Malaguarnera Maria Antonietta Toscano 2007Digestive Diseases and Sciences2007,,11:1
4Acetyl- l -carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy显示文摘Mariano Malaguarnera Rita Bella Marco Vacante Maria Giordano Giulia Malaguarnera Maria Pia Gargante Massimo Motta Antonio Mistretta Liborio Rampello Giovanni Pennisi 2011Scandinavian Journal of Gastroenterology2011,,6:1
5L -carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians:A randomized and controlled clinical trial 显示文摘Malaguarnera M Cammalleri L Gargante MP 2007Am J Clin Nutr2007,86,9:1
6Bifidobacterium combined with fructo - oligosaccharede versus lactulose in the treatment of patients with hepatic encephalo - pathy 显示文摘Malaguamera M Gargante MP Malaguarnera G 2010Eur J Gastmenteml Hepatol2010,22,2:1
7Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy显示文摘Malaguarnera M Gargante MP Malaguarnera G 0,,2:1
8Bifidobacterium combined with fructo- oligosaccharcde vergus lactulose in the treatment of patients with hepatic encephalopathy显示文摘Malaguarnera M Gargante MP Malaguamera G 2010Eur J Gastroenterol Hepatol2010,22,2:1
9L-carnitine supplementation to diet : a new tool in treatment of nonalcoholic steatohepatitis-a randomized and controlled clinical trial 显示文摘Malaguarnera M Gargante MP Russo C 2010Am J Gastroenteml2010,105,6:1
10Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy显示文摘Mariano Malaguarnera Maria Pia Gargante Giulia Malaguarnera Mario Salmeri Silvana Mastrojeni Liborio Rampello Giovanni Pennisi Giovanni Li Volti Fabio Galvano 2010European Journal of Gastroenterology & Hepatology2010,,2:1
11L-Carnitine Supple-mentation to Diet:A New Tool in Treatment of Nonalcoholic Steato-hepatitis-A Randomized and Controlled Clinical Trial显示文摘Malaguarnera M Gargante MP Russo C 2010American Journal of Gastroenterology2010,105,6:1
12Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy显示文摘Mariano Malaguarnera Maria Pia Gargante Giulia Malaguarnera Mario Salmeri Silvana Mastrojeni Liborio Rampello Giovanni Pennisi Giovanni Li Volti Fabio Galvano 2010European Journal of Gastroenterology & Hepatology2010,,2:1
13l-Carnitine Treatment Reduces Steatosis in Patients with Chronic Hepatitis C Treated with α-Interferon and Ribavirin显示文摘Marcello Romano Marco Vacante Erika Cristaldi Valentina Colonna Maria Pia Gargante Lisa Cammalleri Mariano Malaguarnera 2008Digestive Diseases and Sciences2008,,4:1
14Acetyl-L- carnitine treatment in minimal hepatic eneephalopath显示文摘Malaguarnera M Gargante MP Cristaldi E 2008Dig Dis Sci2008,53,11:1
15Bifidobac- terium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy 显示文摘Malaguarnera M Gargante MP Malaguarnera G 2010Eur J Gastroenterol Hepatol2010,22,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费